KAHR
PrivateLast Round
Series B
Oct 14, 2025
Est. Valuation
$16M
Total Funding Raised
$114M
Company Overview
KAHR is a biotechnology company that develops innovative drug platforms aimed at activating immune responses by transforming cancer camouflage into signals for the immune system to target and eliminate cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KAHR Comps
Public and private peers based on sector, stage, and business model.
KAHR Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 14, 2025 | ||||
| Series D Extension | Nov 17, 2022 | ||||
| Series D | Jun 16, 2021 | ||||
| Series C | Feb 25, 2020 | ||||
| Series B | Dec 15, 2015 | ||||
VC Round | Sep 11, 2013 |
KAHR Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| aMoon Growth | Series B |
| DSC Investment | Series B |
| Mirae Asset | Series D, Series D Extension |
| Flerie Invest | Series D |
| Myeloma Investment Fund | Series D Extension |
| Consensus Business Group | Series D Extension |
| aMoon | Series D Extension, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2025
$22M round completed.
KAHR Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KAHR's valuation, stock price, and market status.
